motaz lybia 2014 final

MSD LYBIA BONE BUSINESS REVIEW

Market over viewTotal potential Account number (private

+public) in average 250 COVERAGE ACCOUNT

Total potential pharmacies in averageClass TRIPOLI MASRATA BENGHAZIA 160 40 80B 340 130 220TOTAL (970)

500 170 300

Total coverage all specialties in averageAREA TRIPOLI

(WEST)BENGHAZI (EAST)

TOTAL

NUMBER 1550 650 2200

BONE LINE COVERAGE IN 2014SP. TRIPOLI

(WEST AREA)

BENGHAZI(EAST AREA|)

TOTAL K.O.L

SPEAKER

ORTHOPEDIC 200 50 250 7 1RHUMATOLOGY 18 9 27 3ENDOCRINOLOGY(OSTEOPOROSISE)

7 3 10 2

NEURO SURG. 10 5 15 3GP (IM) 20 8 27

TOTAL 330

ARCOXIA 2010 (7 TABLET)

ARCOXIA 2012 (7 TABLET)

ARCOXIA2013 (7,14 TABLET)

0 10000 20000 30000 40000 50000 60000

ARCOXIA

2013 GR% 326%

2014 GR% +4%

y 2013 y 2014515005200052500530005350054000545005500055500

Arcoxia

Axis Title

37524 17457

GR % +42 packs

14 tab.packs 7 &14 tab,

24%

29%

46%

ARCOXIAARC 60 ARC90 ARC 120

2014 success story PenetrationAll sectors

Tender(mso –

hospitals direct orders)

Private big accounts polyclinics

FOSAVANCE FOSAMAX0200400600800

10001200

2014

Libya standalone

Dubai 16 customer

Barcelona 4 customer

2015